Clinical Trial: Medytoxin® Treatment in Patients With Benign Masseteric Hypertrophy

Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional




Official Title: A Randomized, Double-blind, Multi-center, Phase II Optimal Dose-finding Study to Determine Safety and Efficacy of Medytoxin® in Subjects in Benign Masseteric Hypertrophy

Brief Summary: This study design is A Randomized, Double-blind, Multi-center, Phase II Optimal Dose-finding Study to Determine the Safety and Efficacy of Meditoxin® in Subjects in Benign Masseteric Hypertrophy.